title: Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system.
abstract: The circumventricular organs (CVOs) lack a well-formed blood-brain barrier and produce superoxide in response to angiotensin II and other hypertensive stimuli. This increase in central superoxide has been implicated in the regulation of blood pressure. The extracellular superoxide dismutase (SOD3) is highly expressed in cells associated with CVOs and particularly with tanycytes lining this region. To understand the role of SOD3 in the CVOs in blood pressure regulation, we performed intracerebroventricular injection an adenovirus encoding Cre-recombinase (5x10(8) particles per milliliter) in mice with loxP sites flanking the SOD3 coding region (SOD3(loxp/loxp) mice). An adenovirus encoding red-fluorescent protein was injected as a control. Deletion of CVO SOD3 increased baseline blood pressure modestly and markedly augmented the hypertensive response to low-dose angiotensin II (140 ng/kg per day), whereas intracerebroventricular injection of adenovirus encoding red-fluorescent protein had minimal effects on these parameters. Adenovirus encoding Cre-recombinase-treated mice exhibited increased sympathetic modulation of heart rate and blood pressure variability, increased vascular superoxide production, and T-cell activation as characterized by increased circulating CD69(+)/CD3(+) cells. Deletion of CVO SOD3 also markedly increased vascular T-cell and leukocyte infiltration caused by angiotensin II. We conclude that SOD3 in the CVO plays a critical role in the regulation of blood pressure, and its loss promotes T-cell activation and vascular inflammation, in part by modulating sympathetic outflow. These findings provide insight into how central signals produce vascular inflammation in response to hypertensive stimuli, such as angiotensin II.
authors.affiliation: Division of Cardiology, Lowance Center of Human Immunology, Department of Medicine, Emory University School of Medicine, Atlanta, Ga 30322, USA.
authors.forename: Heinrich E
authors.initials: HE
authors.lastname: Lob
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Marvar
authors.forename: Tomasz J
authors.initials: TJ
authors.lastname: Guzik
authors.forename: Shraya
authors.initials: S
authors.lastname: Sharma
authors.forename: Louise A
authors.initials: LA
authors.lastname: McCann
authors.forename: Cornelia
authors.initials: C
authors.lastname: Weyand
authors.forename: Frank J
authors.initials: FJ
authors.lastname: Gordon
authors.forename: David G
authors.initials: DG
authors.lastname: Harrison
mesh_terms: D000256:Adenoviridae; D000804:Angiotensin II / Q000378:metabolism*; D000818:Animals; D001795:Blood Pressure Determination; D002490:Central Nervous System / Q000187:drug effects / Q000201:enzymology*; D004195:Disease Models, Animal; D006339:Heart Rate / Q000502:physiology; D006973:Hypertension / Q000378:metabolism* / Q000503:physiopathology; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism; D018836:Inflammation Mediators / Q000032:analysis; D019426:Integrases / Q000494:pharmacology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018384:Oxidative Stress; D012333:RNA, Messenger / Q000032:analysis; D011897:Random Allocation; D017382:Reactive Oxygen Species / Q000378:metabolism; D013482:Superoxide Dismutase / Q000378:metabolism*
chemical_list: D018836:Inflammation Mediators; D012333:RNA, Messenger; D017382:Reactive Oxygen Species; D000804:Angiotensin II; D013482:Superoxide Dismutase; C045073:Cre recombinase; D019426:Integrases